Indicated for: cystic fibrosis
Route of administration: oral
Substance: ivacaftor (CFTR modulator)
ATC: R07AX02 (Respiratory system | Other respiratory system products)
Ivacaftor is a medication used for the treatment of cystic fibrosis in patients with specific CFTR gene mutations. It works by improving the function of the CFTR protein, facilitating chloride transport across cell membranes.
The medication is taken orally, usually twice daily with fat-containing food, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include headache, abdominal pain, diarrhea, or skin rashes. In rare cases, severe hepatic reactions or elevated liver enzymes may occur.
Ivacaftor is not recommended for patients with hypersensitivity to this medication or severe hepatic impairment.